|Mr. Richard J. DePiano Jr.||Chief Exec. Officer, Pres, Gen. Counsel and Director||194.22k||N/A||51|
|Mr. Mark G. Wallace||COO and Principal Financial & Accounting Officer||154.81k||N/A||47|
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and Europe. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; light source and fiber optic products that are used by vitreoretinal surgeons during surgery; and AXIS image management system for managing images through the Web from various devices regardless of modality, manufacturer, or location. The company markets its products through independent sales representatives primarily to teaching institutions, hospitals, and eye surgery centers. Escalon Medical Corp. was founded in 1987 and is based in Wayne, Pennsylvania.
Escalon Medical Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.